MiMedx Group

(NASDAQ) MDXG

Current Price$3.63

Market Cap$546.73M

Since IPO (2008)-28%

5 Year-62%

1 Year-42%

1 Month-7%

MiMedx Group Financials at a Glance

Market Cap

$546.73M

Revenue (TTM)

$389.42M

Net Income (TTM)

$30.70M

EPS (TTM)

$0.20

P/E Ratio

18.01

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Price

$3.63

Volume

82,825

Open

$3.66

Price

$3.63

Volume

82,825

Open

$3.66

Previous Close

$3.63

Daily Range

$3.57 - $3.67

52-Week Range

$3.02 - $7.99

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Price

$3.63

Volume

82,825

Open

$3.66

Previous Close

$3.63

Daily Range

$3.57 - $3.67

52-Week Range

$3.02 - $7.99

MDXG News

Page 1

MDXG: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MiMedx Group

Industry

Biotechnology

Sector

Health Care

Employees

808

CEO

Joe Capper, MBA

Website

www.mimedx.com

Headquarters

Marietta, GA 30062, US

MDXG Financials

Key Financial Metrics (TTM)

Gross Margin

81%

Operating Margin

10%

Net Income Margin

Return on Equity

14%

Return on Capital

15%

Return on Assets

10%

Earnings Yield

5.55%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$546.73M

Shares Outstanding

148.57M

Volume

82.83K

Avg. Volume

1.29M

Financials (TTM)

Gross Profit

$345.62M

Operating Income

$63.89M

EBITDA

$82.93M

Operating Cash Flow

$74.00M

Capital Expenditure

$1.03M

Free Cash Flow

$72.97M

Cash & ST Invst.

$166.12M

Total Debt

$22.53M

MiMedx Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$58.99M

-33.1%

Gross Profit

$41.62M

-41.9%

Gross Margin

70.56%

N/A

Market Cap

$546.73M

N/A

Market Cap/Employee

$653.20K

N/A

Employees

837

N/A

Net Income

$10.86M

-254.6%

EBITDA

$14.43M

-225.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$158.27M

+80.3%

Accounts Receivable

$46.03M

-26.1%

Inventory

$26.23M

+9.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$1.50M

+33.3%

Return on Assets

9.94%

N/A

Return on Invested Capital

14.99%

N/A

Free Cash Flow

$1.31M

-73.4%

Operating Cash Flow

$1.88M

-64.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ATAIAtai Beckley N.V

ATAIAtai Beckley N.V$4.20+1.57%

SANASana Biotechnology, Inc.

SANASana Biotechnology, Inc.$3.41+4.28%

CVACCureVac N.V.

CVACCureVac N.V.$4.66+0.00%

RAPPRapport Therapeutics, Inc. Common Stock

RAPPRapport Therapeutics, Inc. Common Stock$35.53+4.84%

INVAInnoviva, Inc.

INVAInnoviva, Inc.$22.99-0.52%

TSHATaysha Gene Therapies, Inc.

TSHATaysha Gene Therapies, Inc.$6.64+4.90%

SNDXSyndax Pharmaceuticals, Inc.

SNDXSyndax Pharmaceuticals, Inc.$19.96+4.45%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$7.84+2.39%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.18+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.69-0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.91-0.01%

NCLHNorwegian Cruise Line

NCLHNorwegian Cruise Line$17.20-0.09%

ADTADT

ADTADT$7.06-0.06%

BBBlackBerry

BBBlackBerry$5.58+0.03%

Questions About MDXG

What is the current price of MiMedx Group?

MiMedx Group is trading at $3.63 per share.

What is the 52-week range for MiMedx Group?

Over the past 52 weeks, MiMedx Group has traded between $3.03 and $7.99.

How much debt does MiMedx Group have?

As of the most recent reporting period, MiMedx Group reported total debt of $17.59M.

How much cash does MiMedx Group have on hand?

MiMedx Group reported $159.77M in cash and cash equivalents in its most recent financial results.

What is MiMedx Group’s dividend yield?

MiMedx Group does not currently have a dividend yield.

MiMedx Group

MiMedx Group Financials at a Glance

MDXG News

Why Shares of MiMedx Are Collapsing Today

Here's Why MiMedx Group Shares Are Imploding 30% Today

Here's Why MiMedx Group, Inc. Gained 16.6% in September

Here's Why MiMedx Group Inc. Rose 24.7% in August

Why Dillard's, MiMedx Group, and Global Net Lease Slumped Today

Yet Another Setback Caused MiMedx Group Shares to Tumble Today

Here's Why MiMedx Group Inc. Stock Is Falling Today

Why MiMedx Group Shares Skyrocketed 18% Today

MDXG: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About MiMedx Group

MDXG Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

MiMedx Group Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MDXG

What is the current price of MiMedx Group?

What is the 52-week range for MiMedx Group?

How much debt does MiMedx Group have?

How much cash does MiMedx Group have on hand?

What is MiMedx Group’s dividend yield?

Premium Investing Services